Search

Celeste A. Roney

Examiner (ID: 19047, Phone: (571)272-5192 , Office: P/1612 )

Most Active Art Unit
1612
Art Unit(s)
1612
Total Applications
873
Issued Applications
472
Pending Applications
148
Abandoned Applications
293

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16760946 [patent_doc_number] => 20210106527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-15 [patent_title] => COMPOSITIONS, METHODS AND USES OF MESSENGER RNA [patent_app_type] => utility [patent_app_number] => 17/066919 [patent_app_country] => US [patent_app_date] => 2020-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22745 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -43 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17066919 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/066919
Compositions, methods and uses of messenger RNA Oct 8, 2020 Issued
Array ( [id] => 17633852 [patent_doc_number] => 11344557 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-31 [patent_title] => Corticotropin releasing factor receptor antagonists [patent_app_type] => utility [patent_app_number] => 17/063592 [patent_app_country] => US [patent_app_date] => 2020-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 21440 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17063592 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/063592
Corticotropin releasing factor receptor antagonists Oct 4, 2020 Issued
Array ( [id] => 16596460 [patent_doc_number] => 20210022991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => ORAL FILM FORMULATION FOR MODULATING ABSORPTION PROFILE [patent_app_type] => utility [patent_app_number] => 17/063644 [patent_app_country] => US [patent_app_date] => 2020-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9408 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17063644 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/063644
Oral film formulation for modulating absorption profile Oct 4, 2020 Issued
Array ( [id] => 16939827 [patent_doc_number] => 11052041 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-07-06 [patent_title] => Nanotechnology-based nostril drops for relief of respiratory ailments [patent_app_type] => utility [patent_app_number] => 17/060272 [patent_app_country] => US [patent_app_date] => 2020-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 9210 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17060272 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/060272
Nanotechnology-based nostril drops for relief of respiratory ailments Sep 30, 2020 Issued
Array ( [id] => 19700161 [patent_doc_number] => 12194161 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-01-14 [patent_title] => Living body-adhesive sheet [patent_app_type] => utility [patent_app_number] => 17/033679 [patent_app_country] => US [patent_app_date] => 2020-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 10229 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17033679 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/033679
Living body-adhesive sheet Sep 25, 2020 Issued
Array ( [id] => 16568897 [patent_doc_number] => 20210007903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-14 [patent_title] => Analgesic Nose Plugs [patent_app_type] => utility [patent_app_number] => 17/031487 [patent_app_country] => US [patent_app_date] => 2020-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4238 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17031487 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/031487
Analgesic Nose Plugs Sep 23, 2020 Abandoned
Array ( [id] => 18536002 [patent_doc_number] => 20230241089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => STING AGONIST COMPRISING EXOSOMES FOR TREATING NEUROIMMUNOLOGICAL DISORDERS [patent_app_type] => utility [patent_app_number] => 17/754177 [patent_app_country] => US [patent_app_date] => 2020-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42401 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17754177 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/754177
STING AGONIST COMPRISING EXOSOMES FOR TREATING NEUROIMMUNOLOGICAL DISORDERS Sep 23, 2020 Pending
Array ( [id] => 16539292 [patent_doc_number] => 20200405705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => Atropine Pharmaceutical Compositions [patent_app_type] => utility [patent_app_number] => 17/016186 [patent_app_country] => US [patent_app_date] => 2020-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11702 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17016186 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/016186
Atropine pharmaceutical compositions Sep 8, 2020 Issued
Array ( [id] => 19075351 [patent_doc_number] => 11944694 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-02 [patent_title] => Foaming oral care compositions [patent_app_type] => utility [patent_app_number] => 17/008684 [patent_app_country] => US [patent_app_date] => 2020-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18490 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17008684 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/008684
Foaming oral care compositions Aug 31, 2020 Issued
Array ( [id] => 18574222 [patent_doc_number] => 11730728 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-22 [patent_title] => Atropine pharmaceutical compositions [patent_app_type] => utility [patent_app_number] => 17/007900 [patent_app_country] => US [patent_app_date] => 2020-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11703 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17007900 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/007900
Atropine pharmaceutical compositions Aug 30, 2020 Issued
Array ( [id] => 16523659 [patent_doc_number] => 20200397739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-24 [patent_title] => SYNERGISTIC COMPOSITION OF VITAMIN C AND VITAMIN K1, AND COMPOSITIONS THEREOF FOR THE TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 17/007587 [patent_app_country] => US [patent_app_date] => 2020-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5522 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17007587 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/007587
SYNERGISTIC COMPOSITION OF VITAMIN C AND VITAMIN K1, AND COMPOSITIONS THEREOF FOR THE TREATMENT OF CANCER Aug 30, 2020 Abandoned
Array ( [id] => 18574221 [patent_doc_number] => 11730727 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-22 [patent_title] => Atropine pharmaceutical compositions [patent_app_type] => utility [patent_app_number] => 17/007816 [patent_app_country] => US [patent_app_date] => 2020-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11711 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17007816 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/007816
Atropine pharmaceutical compositions Aug 30, 2020 Issued
Array ( [id] => 17880309 [patent_doc_number] => 20220295786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-22 [patent_title] => BUOYANT ARTICLES COMPRISING LARVICIDES AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/637220 [patent_app_country] => US [patent_app_date] => 2020-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8936 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -62 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17637220 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/637220
BUOYANT ARTICLES COMPRISING LARVICIDES AND METHODS OF USING THE SAME Aug 20, 2020 Pending
Array ( [id] => 17911204 [patent_doc_number] => 20220313599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => IMPLANTABLE CONSTRUCTS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/633716 [patent_app_country] => US [patent_app_date] => 2020-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22559 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17633716 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/633716
IMPLANTABLE CONSTRUCTS AND USES THEREOF Aug 6, 2020 Pending
Array ( [id] => 16435597 [patent_doc_number] => 20200352922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-12 [patent_title] => SUSTAINED-RELEASE TOPICALLY ADMINISTERED AGENT [patent_app_type] => utility [patent_app_number] => 16/939974 [patent_app_country] => US [patent_app_date] => 2020-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15837 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 228 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16939974 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/939974
SUSTAINED-RELEASE TOPICALLY ADMINISTERED AGENT Jul 26, 2020 Abandoned
Array ( [id] => 18018854 [patent_doc_number] => 20220370353 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2022-11-24 [patent_title] => BLENDED FORMULATIONS [patent_app_type] => utility [patent_app_number] => 16/923810 [patent_app_country] => US [patent_app_date] => 2020-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28967 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16923810 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/923810
BLENDED FORMULATIONS Jul 7, 2020 Abandoned
Array ( [id] => 18018854 [patent_doc_number] => 20220370353 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2022-11-24 [patent_title] => BLENDED FORMULATIONS [patent_app_type] => utility [patent_app_number] => 16/923810 [patent_app_country] => US [patent_app_date] => 2020-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28967 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16923810 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/923810
BLENDED FORMULATIONS Jul 7, 2020 Abandoned
Array ( [id] => 20525335 [patent_doc_number] => 12543752 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-02-10 [patent_title] => Method for dehydrating liquid, semi-liquid or paste-like products, including a pressure cryogenic step and a lyophilization step [patent_app_type] => utility [patent_app_number] => 17/597370 [patent_app_country] => US [patent_app_date] => 2020-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 3025 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17597370 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/597370
Method for dehydrating liquid, semi-liquid or paste-like products, including a pressure cryogenic step and a lyophilization step Jul 5, 2020 Issued
Array ( [id] => 16568986 [patent_doc_number] => 20210007992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-14 [patent_title] => MICROPARTICLE FORMULATIONS OF ADENOSINE RECEPTOR ANTAGONISTS FOR TREATING CANCER [patent_app_type] => utility [patent_app_number] => 16/919614 [patent_app_country] => US [patent_app_date] => 2020-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7403 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16919614 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/919614
MICROPARTICLE FORMULATIONS OF ADENOSINE RECEPTOR ANTAGONISTS FOR TREATING CANCER Jul 1, 2020 Abandoned
Array ( [id] => 16523631 [patent_doc_number] => 20200397711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-24 [patent_title] => MICROPARTICLE COMPOSITIONS FOR TREATMENT OF INFECTION OR DISEASE, METHODS OF MAKING THE SAME, AND METHODS OF TREATING SUBJECTS WITH MICROPARTICLE COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 16/908586 [patent_app_country] => US [patent_app_date] => 2020-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10174 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16908586 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/908586
MICROPARTICLE COMPOSITIONS FOR TREATMENT OF INFECTION OR DISEASE, METHODS OF MAKING THE SAME, AND METHODS OF TREATING SUBJECTS WITH MICROPARTICLE COMPOSITIONS Jun 21, 2020 Abandoned
Menu